Skip to content

The effect of dexmedetomidine drug in transverse abdominal plane block after cesarean section

The effect of dexmedetomidine drug in transverse abdominal plane block in pain control

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220706055402N5
Enrollment
82
Registered
2024-02-02
Start date
2024-02-07
Completion date
Unknown
Last updated
2024-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Investigating the effect of dexmedetomidine in TAP block to reduce pain after caesarean section. Pain, unspecified

Interventions

Intervention 1: Control group: One group of people (group R) is injected with 20 cc of 0.2% vacaine. Intervention 2: Control group: The other group (RD group) was injected with 20 cc of 0.2% vacaine a

Sponsors

Ahvaz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 38 Years

Inclusion criteria

Inclusion criteria: Pregnant women aged 18-38 are candidates for elective caesarean section and have undergone spinal anesthesia for the operation.

Exclusion criteria

Exclusion criteria: Absence or withdrawal of consent, coagulation disorders, abuse of narcotics and sedatives, history of allergy and drug reaction to the studied drugs, severe mental disorders, conversion of spinal anesthesia to general anesthesia.

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale (VAS). Timepoint: It will be done 1 hour later, 6, 12 and 24 hours later. Method of measurement: (0 = no pain and 10 = worst imaginable pain) is measured.

Secondary

MeasureTime frame
Mean arterial blood pressure (MAP). Timepoint: It will be done at time zero, 1 hour later, 6, 12 and 24 hours later. Method of measurement: Reading from the monitoring device.;Heart beat. Timepoint: It will be done at time zero, 1 hour later, 6, 12 and 24 hours later. Method of measurement: Reading from the monitoring device.;Arterial blood oxygen. Timepoint: It will be done at time zero, 1 hour later, 6, 12 and 24 hours later. Method of measurement: Reading from the monitoring device.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Moftakhar

Ahvaz University of Medical Sciences

moftakhar-f@ajums.ac.ir+98 61 3338 3372

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026